Rola Hammoud
Rola Hammoud is a postdoctoral scientist in Dr. Daniel Drucker’s lab at Mount Sinai Hospital, where she is researching the gut hormone GIP in relation to tirzepatide, a dual-action drug for diabetes and weight loss. With a background in nutritional science, she emphasizes the complex physiological processes influencing weight loss and appetite control, challenging the notion that these issues are solely a matter of willpower.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Dr. Rola Hammoud is studying the mechanism of the gut hormone GIP, which works with GLP-1 in tirzepatide.
8